Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Bayer HealthCare Pharmaceuticals 

340 Changebridge Road
Pine Brook, New Jersey 07058 U.S.A.

Phone: 973-487-2000

800 Dwight Way

Berkeley  California  94701  U.S.A.
Phone: 510-705-5000 Fax: 510-705-7878



 Company News
Bayer HealthCare Pharmaceuticals (BAYA.F) Has Selected Biologics, Inc. (NC) As A Limited Distribution Network Provider For NEXAVAR (Sorafenib) And STIVARGA (Regorafenib) 2/23/2015 12:49:05 PM
ESMO 2014 To Feature New Oncology Data From Across Bayer HealthCare Pharmaceuticals (BAYA.F) Franchise 9/24/2014 8:18:20 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) And Orion Corporation Initiate Phase 3 Trial Of ODM-201 In Men With High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 9/16/2014 8:05:55 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) May Add 80,000-Square-Foot Product-Testing Facility In Berkeley, California 8/29/2014 6:26:32 AM
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014 7:20:37 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) Introduces New Bayer Inserter For Mirena® (Levonorgestrel-Releasing Intrauterine System) 52 Mg 6/2/2014 9:58:23 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: Phase 3 DECISION Trial Of NEXAVAR (Sorafenib) In Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory To Radioactive Iodine Published In The Lancet 4/24/2014 8:15:11 AM
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014 6:25:33 AM
Bayer HealthCare Pharmaceuticals (BAYA.F)' Long-Acting Hemophilia Drug Shown To Be Effective 2/18/2014 7:37:07 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets 10/28/2013 11:09:30 AM